Within the differentiation category, EPCAM, CDH1 and CK18 were significantly associated with tumor relapse (Fig. 5A(ii–iv), whereas POU5F1 was the major contributor within the pluripotency category (Fig. 5A(vi)). This evidence concerns the gene KRT18 and neoplasm.